Medicare Program; Request for Renewal of Deeming Authority of the Utilization Review Accreditation Commission (URAC) for Health Maintenance Organizations and Preferred Provider Organizations, 66271-66273 [2018-27802]
Download as PDF
66271
Federal Register / Vol. 83, No. 246 / Wednesday, December 26, 2018 / Notices
objectives for treatment of tuberculosis
(TB), prevention of multi-drug
resistance, and surveillance programs,
CDC is requesting approval from the
Office of Management and Budget to
continue information collection from
participants in the Model Performance
Evaluation Program for Mycobacterium
tuberculosis Susceptibility Testing. This
revision request includes (a)
modification of the Participant Biosafety
Compliance Letter of Agreement to
contain language to ensure that
participants understand and comply
with biosafety guidelines using quality
management system practices; (b)
modification of Instructions to
Participants Letter to include detailed
instructions for online data entry of DST
results; (c) modification of MPEP
Mycobacterium tuberculosis Results
Worksheet to include fields for entering
methods used for conventional and
molecular DST; (d)addition of a MPEP
Mycobacterium tuberculosis Minimum
Inhibitory Concentration (MIC) Results
form for laboratories performing this
procedure to enter results manually and
submit by email to TBMPEP@cdc.gov;
and (e) reduction in request for burden
hours from 156 hours to 129 hours due
to fewer laboratories participating in the
program compared to the previous
submission request.
While the overall number of cases of
TB in the U.S. has decreased, rates still
remain high among foreign-born
persons, prisoners, homeless
populations, and individuals infected
with HIV in major metropolitan areas.
To reach the goal of eliminating TB, the
Model Performance Evaluation Program
for Mycobacterium tuberculosis Drug
Susceptibility Testing is used to monitor
and evaluate performance and practices
among national laboratories performing
M. tuberculosis susceptibility testing.
Participation in this program is one way
laboratories can ensure high-quality
laboratory testing, resulting in accurate
and reliable testing results.
Revision of this information
collection provides CDC with an
evaluation program to assess the ability
of the laboratories to test for drug
resistant M. tuberculosis strains,
laboratories also have a self-assessment
tool to aid in optimizing their skills in
susceptibility testing. The information
obtained from the laboratories on
susceptibility practices and procedures
is used to establish variables related to
good performance, assessing training
needs, and aid with the development of
practice standards.
Participants in this program include
domestic clinical and public health
laboratories. Data collection from
laboratory participants occurs twice per
year. The data collected in this program
will include the susceptibility test
results of primary and secondary drugs,
drug concentrations, and test methods
performed by laboratories on a set of
performance evaluation (PE) samples.
The PE samples are sent to participants
twice a year. Participants also report
demographic data such as laboratory
type and the number of tests performed
annually.
There is no cost to respondents to
participate other than their time. Total
burden hours is 129.
ESTIMATED ANNUALIZED BURDEN HOURS
Form name
Domestic Laboratories ....................................
Participant Biosafety Compliance Letter of
Agreement.
MPEP Mycobacterium tuberculosis Results
Worksheet.
Online Survey Instrument ..............................
Minimum Inhibitory Concentration (MIC) Results Form.
Jeffrey M. Zirger,
Acting Lead, Information Collection Review
Office, Office of Scientific Integrity, Office
of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2018–27853 Filed 12–21–18; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[CMS–4188–PN]
amozie on DSK3GDR082PROD with NOTICES1
Number of
respondents
Type of respondents
Medicare Program; Request for
Renewal of Deeming Authority of the
Utilization Review Accreditation
Commission (URAC) for Health
Maintenance Organizations and
Preferred Provider Organizations
Centers for Medicare &
Medicaid Services (CMS), HHS.
AGENCY:
VerDate Sep<11>2014
20:07 Dec 21, 2018
Jkt 247001
ACTION:
Proposed notice.
This proposed notice
announces that CMS is considering
granting approval of the Utilization
Review Accreditation Commission’s
(URAC) renewal application for
Medicare Advantage ‘‘deeming
authority’’ of Health Maintenance
Organizations and Preferred Provider
Organizations. This new 6-year term of
approval would begin on the date of
publication of the final notice. This
notice also announces a 30-day period
for the public to submit comments on
CMS’ renewal of the application.
DATES: To be assured consideration,
comments must be received at one of
the addresses provided below, no later
than 5 p.m. January 25, 2019.
ADDRESSES: In commenting, refer to file
code CMS–4188–PN. Because of staff
and resource limitations, we cannot
accept comments by facsimile (FAX)
transmission.
SUMMARY:
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
Number of
responses
per
respondent
Average
burden per
response
(in hours)
80
1
5/60
80
2
30/60
80
4
2
2
15/60
15/60
Comments, including mass comment
submissions, must be submitted in one
of the following three ways (please
choose only one of the ways listed):
1. Electronically. You may submit
electronic comments on this regulation
to https://www.regulations.gov. Follow
the ‘‘Submit a comment’’ instructions.
2. By regular mail. You may mail
written comments to the following
address ONLY: Centers for Medicare &
Medicaid Services, Department of
Health and Human Services, Attention:
CMS–4188–PN, P.O. Box 8016,
Baltimore, MD 21244–8016.
Please allow sufficient time for mailed
comments to be received before the
close of the comment period.
3. By express or overnight mail. You
may send written comments to the
following address ONLY: Centers for
Medicare & Medicaid Services,
Department of Health and Human
Services, Attention: CMS–4188–PN,
E:\FR\FM\26DEN1.SGM
26DEN1
66272
Federal Register / Vol. 83, No. 246 / Wednesday, December 26, 2018 / Notices
Mail Stop C4–26–05, 7500 Security
Boulevard, Baltimore, MD 21244–1850.
FOR FURTHER INFORMATION CONTACT: Greg
McDonald, (410) 786–8941; or Nick
Proy, (410) 786–8407.
SUPPLEMENTARY INFORMATION:
Inspection of Public Comments: All
comments received before the close of
the comment period are available for
viewing by the public, including any
personally identifiable or confidential
business information that is included in
a comment. We post all comments
received before the close of the
comment period on the following
website as soon as possible after they
have been received: https://
www.regulations.gov. Follow the search
instructions on that website to view
public comments.
amozie on DSK3GDR082PROD with NOTICES1
I. Background
Under the Medicare program, eligible
beneficiaries may receive covered
services through a Medicare Advantage
(MA) organization that contracts with
CMS. The regulations specifying the
Medicare requirements that must be met
for a Medicare Advantage Organization
(MAO) to enter into a contract with
CMS are located at 42 CFR part 422.
These regulations implement Part C of
Title XVIII of the Social Security Act
(the Act), which specifies the services
that an MAO must provide and the
requirements that the organization must
meet to be an MA contractor. Other
relevant sections of the Act are Parts A
and B of Title XVIII and Part A of Title
XI pertaining to the provision of
services by Medicare certified providers
and suppliers. Generally, for an entity to
be an MA organization, the organization
must be licensed by the state as a risk
bearing organization, as set forth in 42
CFR part 422.
As a method of assuring compliance
with certain Medicare requirements, an
MA organization may choose to become
accredited by a CMS approved
accrediting organization (AO). By virtue
of its accreditation by a CMS-approved
AO, the MA organization may be
‘‘deemed’’ compliant in one or more
requirements set forth in section
1852(e)(4)(B) of the Act. For CMS to
recognize an AO’s accreditation
program as establishing an MA plan’s
compliance with our requirements, the
AO must prove to CMS that their
standards are at least as stringent as
Medicare requirements for MA
organizations. MA organizations that are
licensed as health maintenance
organizations (HMOs) or preferred
provider organizations (PPOs) and are
accredited by an approved accrediting
organization may receive, at their
VerDate Sep<11>2014
20:07 Dec 21, 2018
Jkt 247001
request, ‘‘deemed’’ status for CMS
requirements for the deemable areas. At
this time, recognition of accreditation
does not include the Part D areas of
review set out at 42 CFR 423.165(b).
AOs that apply for MA deeming
authority are generally recognized by
the health care industry as entities that
accredit HMOs and PPOs. As we specify
at § 422.157(b)(2)(ii) the term for which
an AO may be approved by CMS may
not exceed 6 years. For continuing
approval, the AO must apply to CMS to
renew their ‘‘deeming authority’’ for a
subsequent approval period.
The Utilization Review Accreditation
Commission (URAC) was approved as a
CMS approved accreditation
organization for MA deeming of HMOs
on May 26, 2012, and that term lapsed
on May 25, 2018 prior to our decision
on its renewal application. On October
13, 2017 URAC submitted its initial
application to renew its deeming
authority. On that same date, URAC
submitted materials requested by CMS
that included information intended to
address the requirements set out at
§ 422.158(a) through (b) that are
prerequisites for receiving approval of
its accreditation program from CMS.
CMS subsequently requested that
additional materials, including
revisions, be submitted by URAC to
satisfy these requirements.
II. Provisions of the Proposed Notice
The purpose of this notice is to notify
the public of URAC’s request to renew
its Medicare Advantage deeming
authority for HMOs and PPOs. URAC
submitted all the necessary materials
(including its standards and monitoring
protocol) to enable us to make a
determination concerning its request for
approval as an accreditation
organization for CMS. This renewal
application was determined to be
complete on November 8, 2018. Under
section 1852(e)(4) of the Act and
§ 422.158 (federal review of accrediting
organizations), our review and
evaluation of URAC will be conducted
as discussed below.
A. Components of the Review Process
The review of URAC’s renewal
application for approval of MA deeming
authority includes, but is not limited to,
the following components:
• The types of MA plans that it would
review as part of its accreditation
process.
• A detailed comparison of the AO’s
accreditation requirements and
standards with the Medicare
requirements (for example, a crosswalk)
in the following 5 areas: Quality
Improvement, Anti-Discrimination,
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
Confidentiality and Accuracy of
Enrollee Records, Information on
Advance Directives, and Provider
Participation Rules.
• Detailed information about the
organization’s survey process,
including—
++ Frequency of surveys and whether
surveys are announced or unannounced.
++ Copies of survey forms, and
guidelines and instructions to
surveyors.
++ Descriptions of—
—The survey review process and the
accreditation status decision making
process;
—The procedures used to notify
accredited MA organizations of
deficiencies and to monitor the
correction of those deficiencies; and
—The procedures used to enforce
compliance with accreditation
requirements.
• Detailed information about the
individuals who perform surveys for the
accreditation organization, including—
++ The size and composition of
accreditation survey teams for each type
of plan reviewed as part of the
accreditation process;
++ The education and experience
requirements surveyors must meet;
++ The content and frequency of the
in-service training provided to survey
personnel;
++ The evaluation systems used to
monitor the performance of individual
surveyors and survey teams; and
++ The organization’s policies and
practice for the participation, in surveys
or in the accreditation decision process,
by an individual who is professionally
or financially affiliated with the entity
being surveyed.
• A description of the organization’s
data management and analysis system
for the surveys and accreditation
decisions, including the kinds of
reports, tables, and other displays
generated by that system.
• A description of the organization’s
procedures for responding to and
investigating complaints against
accredited organizations, including
policies and procedures regarding
coordination of these activities with
appropriate licensing bodies and
ombudsmen programs.
• A description of the organization’s
policies and procedures for the
withholding or removal of accreditation
for failure to meet the accreditation
organization’s standards or
requirements, and other actions the
organization takes in response to
noncompliance with its standards and
requirements.
• A description of all types (for
example, full, partial) and categories (for
E:\FR\FM\26DEN1.SGM
26DEN1
Federal Register / Vol. 83, No. 246 / Wednesday, December 26, 2018 / Notices
example, provisional, conditional,
temporary) of accreditation offered by
the organization, the duration of each
type and category of accreditation and a
statement identifying the types and
categories that would serve as a basis for
accreditation if CMS approves the
accreditation organization.
• A list of all currently accredited MA
organizations and the type, category,
and expiration date of the accreditation
held by each of them.
• A list of all full and partial
accreditation surveys scheduled to be
performed by the accreditation
organization.
• The name and address of each
person with an ownership or control
interest in the accreditation
organization.
• CMS will also consider URAC’s
past performance in the deeming
program and results of recent deeming
validation reviews, or look-behind
audits conducted as part of continuing
federal oversight of the deeming
program under § 422.157(d).
B. Notice Upon Completion of
Evaluation
Upon completion of our evaluation,
including evaluation of comments
received as a result of this notice, we
will publish a notice in the Federal
Register announcing the result of our
evaluation. Section 1852(e)(4)(C) of the
Act provides a statutory timetable to
ensure that our review of deeming
applications is conducted in a timely
manner. The Act provides us with 210
calendar days after the date of receipt of
an application to complete our survey
activities and application review
process. At the end of the 210-day
period, we must publish an approval or
denial of the application in the Federal
Register.
amozie on DSK3GDR082PROD with NOTICES1
III. Collection of Information
Requirements
This document does not impose
information collection requirements,
that is, reporting, recordkeeping or
third-party disclosure requirements.
Consequently, there is no need for
review by the Office of Management and
Budget under the authority of the
Paperwork Reduction Act of 1995 (44
U.S.C. 3501 et seq.).
IV. Response to Comments
Because of the large number of public
comments we normally receive on
Federal Register documents, we are not
able to acknowledge or respond to them
individually. We will consider all
comments we receive by the date and
time specified in the DATES section of
this preamble, and, when we proceed
VerDate Sep<11>2014
20:07 Dec 21, 2018
Jkt 247001
with a subsequent document, we will
respond to the comments in the
preamble to that document.
Dated: December 14, 2018.
Seema Verma,
Administrator, Centers for Medicare &
Medicaid Services.
[FR Doc. 2018–27802 Filed 12–21–18; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[CMS–7052–N]
Medicare & Medicaid Programs, and
Other Program Initiatives, and
Priorities; Meeting of the Advisory
Panel on Outreach and Education
(APOE), January 16, 2019
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Notice.
AGENCY:
This notice announces the
next meeting of the Advisory Panel on
Outreach and Education (APOE) (the
Panel) in accordance with the Federal
Advisory Committee Act. The Panel
advises and makes recommendations to
the Secretary of the U.S. Department of
Health and Human Services (HHS) and
the Administrator of the Centers for
Medicare & Medicaid Services (CMS) on
opportunities to enhance the
effectiveness of consumer education
strategies concerning CMS programs,
initiatives, and priorities. This meeting
is open to the public.
DATES:
Meeting Date: Wednesday, January 16,
2019 8:30 a.m. to 4:00 p.m. eastern
standard time (e.s.t).
Deadline for Meeting Registration,
Presentations, Special Accommodations
and Comments: Wednesday, January 2,
2019, 5:00 p.m., e.s.t.
ADDRESSES: Meeting Location: U.S.
Department of Health & Human
Services, Hubert H. Humphrey Building,
200 Independence Avenue SW, Room
705A, Conference Room, Washington,
DC 20201.
Presentations and Written Comments:
Presentations and written comments
should be submitted to: Lynne Johnson,
Acting Designated Federal Official
(DFO), Office of Communications,
Centers for Medicare & Medicaid
Services, 7500 Security Boulevard,
Mailstop S1–05–06, Baltimore, MD
21244–1850 or via email at
Lynne.Johnson@cms.hhs.gov.
Registration: The meeting is open to
the public, but attendance is limited to
SUMMARY:
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
66273
the space available. Persons wishing to
attend this meeting must register at the
website https://www.regonline.com/
apoe2019jan16meeting or by contacting
the Acting DFO listed in the FOR
FURTHER INFORMATION CONTACT section of
this notice, by the date listed in the
DATES section of this notice. Individuals
requiring sign language interpretation or
other special accommodations should
contact the Acting DFO at the address
listed in the ADDRESSES section of this
notice by the date listed in the DATES
section of this notice.
FOR FURTHER INFORMATION CONTACT:
Lynne Johnson, Acting Designated
Federal Official, Office of
Communications, CMS, 7500 Security
Boulevard, Mail Stop S1–05–06,
Baltimore, MD 21244–1850, 410–786–
0090, email Lynne.Johnson@
cms.hhs.gov. Additional information
about the APOE is available on the
internet at: https://www.cms.gov/
Regulations-and-guidance/Guidance/
FACA/APOE.html. Press inquiries are
handled through the CMS Press Office
at (202) 690–6145.
SUPPLEMENTARY INFORMATION:
I. Background
The Advisory Panel for Outreach and
Education (APOE) (the Panel) is
governed by the provisions of Federal
Advisory Committee Act (FACA) (Pub.
L. 92–463), as amended (5 U.S.C.
Appendix 2), which sets forth standards
for the formation and use of federal
advisory committees. The Panel is
authorized by section 1114(f) of the
Social Security Act (42 U.S.C. 1314(f))
and section 222 of the Public Health
Service Act (42 U.S.C. 217a).
The Secretary of the U.S. Department
of Health and Human Services (HHS)
(the Secretary) signed the charter
establishing the Citizen’s Advisory
Panel on Medicare Education 1 (the
predecessor to the APOE) on January 21,
1999 (64 FR 7899, February 17, 1999) to
advise and make recommendations to
the Secretary and the Administrator of
the Centers for Medicare & Medicaid
Services (CMS) on the effective
implementation of national Medicare
education programs, including with
respect to the Medicare+Choice (M+C)
program added by the Balanced Budget
Act of 1997 (Pub. L. 105–33).
The Medicare Modernization Act of
2003 (MMA) (Pub. L. 108–173)
expanded the existing health plan
options and benefits available under the
1 We note that the Citizen’s Advisory Panel on
Medicare Education is also referred to as the
Advisory Panel on Medicare Education (65 FR
4617). The name was updated in the Second
Amended Charter approved on July 24, 2000.
E:\FR\FM\26DEN1.SGM
26DEN1
Agencies
[Federal Register Volume 83, Number 246 (Wednesday, December 26, 2018)]
[Notices]
[Pages 66271-66273]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-27802]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[CMS-4188-PN]
Medicare Program; Request for Renewal of Deeming Authority of the
Utilization Review Accreditation Commission (URAC) for Health
Maintenance Organizations and Preferred Provider Organizations
AGENCY: Centers for Medicare & Medicaid Services (CMS), HHS.
ACTION: Proposed notice.
-----------------------------------------------------------------------
SUMMARY: This proposed notice announces that CMS is considering
granting approval of the Utilization Review Accreditation Commission's
(URAC) renewal application for Medicare Advantage ``deeming authority''
of Health Maintenance Organizations and Preferred Provider
Organizations. This new 6-year term of approval would begin on the date
of publication of the final notice. This notice also announces a 30-day
period for the public to submit comments on CMS' renewal of the
application.
DATES: To be assured consideration, comments must be received at one of
the addresses provided below, no later than 5 p.m. January 25, 2019.
ADDRESSES: In commenting, refer to file code CMS-4188-PN. Because of
staff and resource limitations, we cannot accept comments by facsimile
(FAX) transmission.
Comments, including mass comment submissions, must be submitted in
one of the following three ways (please choose only one of the ways
listed):
1. Electronically. You may submit electronic comments on this
regulation to https://www.regulations.gov. Follow the ``Submit a
comment'' instructions.
2. By regular mail. You may mail written comments to the following
address ONLY: Centers for Medicare & Medicaid Services, Department of
Health and Human Services, Attention: CMS-4188-PN, P.O. Box 8016,
Baltimore, MD 21244-8016.
Please allow sufficient time for mailed comments to be received
before the close of the comment period.
3. By express or overnight mail. You may send written comments to
the following address ONLY: Centers for Medicare & Medicaid Services,
Department of Health and Human Services, Attention: CMS-4188-PN,
[[Page 66272]]
Mail Stop C4-26-05, 7500 Security Boulevard, Baltimore, MD 21244-1850.
FOR FURTHER INFORMATION CONTACT: Greg McDonald, (410) 786-8941; or Nick
Proy, (410) 786-8407.
SUPPLEMENTARY INFORMATION:
Inspection of Public Comments: All comments received before the
close of the comment period are available for viewing by the public,
including any personally identifiable or confidential business
information that is included in a comment. We post all comments
received before the close of the comment period on the following
website as soon as possible after they have been received: https://www.regulations.gov. Follow the search instructions on that website to
view public comments.
I. Background
Under the Medicare program, eligible beneficiaries may receive
covered services through a Medicare Advantage (MA) organization that
contracts with CMS. The regulations specifying the Medicare
requirements that must be met for a Medicare Advantage Organization
(MAO) to enter into a contract with CMS are located at 42 CFR part 422.
These regulations implement Part C of Title XVIII of the Social
Security Act (the Act), which specifies the services that an MAO must
provide and the requirements that the organization must meet to be an
MA contractor. Other relevant sections of the Act are Parts A and B of
Title XVIII and Part A of Title XI pertaining to the provision of
services by Medicare certified providers and suppliers. Generally, for
an entity to be an MA organization, the organization must be licensed
by the state as a risk bearing organization, as set forth in 42 CFR
part 422.
As a method of assuring compliance with certain Medicare
requirements, an MA organization may choose to become accredited by a
CMS approved accrediting organization (AO). By virtue of its
accreditation by a CMS-approved AO, the MA organization may be
``deemed'' compliant in one or more requirements set forth in section
1852(e)(4)(B) of the Act. For CMS to recognize an AO's accreditation
program as establishing an MA plan's compliance with our requirements,
the AO must prove to CMS that their standards are at least as stringent
as Medicare requirements for MA organizations. MA organizations that
are licensed as health maintenance organizations (HMOs) or preferred
provider organizations (PPOs) and are accredited by an approved
accrediting organization may receive, at their request, ``deemed''
status for CMS requirements for the deemable areas. At this time,
recognition of accreditation does not include the Part D areas of
review set out at 42 CFR 423.165(b). AOs that apply for MA deeming
authority are generally recognized by the health care industry as
entities that accredit HMOs and PPOs. As we specify at Sec.
422.157(b)(2)(ii) the term for which an AO may be approved by CMS may
not exceed 6 years. For continuing approval, the AO must apply to CMS
to renew their ``deeming authority'' for a subsequent approval period.
The Utilization Review Accreditation Commission (URAC) was approved
as a CMS approved accreditation organization for MA deeming of HMOs on
May 26, 2012, and that term lapsed on May 25, 2018 prior to our
decision on its renewal application. On October 13, 2017 URAC submitted
its initial application to renew its deeming authority. On that same
date, URAC submitted materials requested by CMS that included
information intended to address the requirements set out at Sec.
422.158(a) through (b) that are prerequisites for receiving approval of
its accreditation program from CMS. CMS subsequently requested that
additional materials, including revisions, be submitted by URAC to
satisfy these requirements.
II. Provisions of the Proposed Notice
The purpose of this notice is to notify the public of URAC's
request to renew its Medicare Advantage deeming authority for HMOs and
PPOs. URAC submitted all the necessary materials (including its
standards and monitoring protocol) to enable us to make a determination
concerning its request for approval as an accreditation organization
for CMS. This renewal application was determined to be complete on
November 8, 2018. Under section 1852(e)(4) of the Act and Sec. 422.158
(federal review of accrediting organizations), our review and
evaluation of URAC will be conducted as discussed below.
A. Components of the Review Process
The review of URAC's renewal application for approval of MA deeming
authority includes, but is not limited to, the following components:
The types of MA plans that it would review as part of its
accreditation process.
A detailed comparison of the AO's accreditation
requirements and standards with the Medicare requirements (for example,
a crosswalk) in the following 5 areas: Quality Improvement, Anti-
Discrimination, Confidentiality and Accuracy of Enrollee Records,
Information on Advance Directives, and Provider Participation Rules.
Detailed information about the organization's survey
process, including--
++ Frequency of surveys and whether surveys are announced or
unannounced.
++ Copies of survey forms, and guidelines and instructions to
surveyors.
++ Descriptions of--
--The survey review process and the accreditation status decision
making process;
--The procedures used to notify accredited MA organizations of
deficiencies and to monitor the correction of those deficiencies; and
--The procedures used to enforce compliance with accreditation
requirements.
Detailed information about the individuals who perform
surveys for the accreditation organization, including--
++ The size and composition of accreditation survey teams for each
type of plan reviewed as part of the accreditation process;
++ The education and experience requirements surveyors must meet;
++ The content and frequency of the in-service training provided to
survey personnel;
++ The evaluation systems used to monitor the performance of
individual surveyors and survey teams; and
++ The organization's policies and practice for the participation,
in surveys or in the accreditation decision process, by an individual
who is professionally or financially affiliated with the entity being
surveyed.
A description of the organization's data management and
analysis system for the surveys and accreditation decisions, including
the kinds of reports, tables, and other displays generated by that
system.
A description of the organization's procedures for
responding to and investigating complaints against accredited
organizations, including policies and procedures regarding coordination
of these activities with appropriate licensing bodies and ombudsmen
programs.
A description of the organization's policies and
procedures for the withholding or removal of accreditation for failure
to meet the accreditation organization's standards or requirements, and
other actions the organization takes in response to noncompliance with
its standards and requirements.
A description of all types (for example, full, partial)
and categories (for
[[Page 66273]]
example, provisional, conditional, temporary) of accreditation offered
by the organization, the duration of each type and category of
accreditation and a statement identifying the types and categories that
would serve as a basis for accreditation if CMS approves the
accreditation organization.
A list of all currently accredited MA organizations and
the type, category, and expiration date of the accreditation held by
each of them.
A list of all full and partial accreditation surveys
scheduled to be performed by the accreditation organization.
The name and address of each person with an ownership or
control interest in the accreditation organization.
CMS will also consider URAC's past performance in the
deeming program and results of recent deeming validation reviews, or
look-behind audits conducted as part of continuing federal oversight of
the deeming program under Sec. 422.157(d).
B. Notice Upon Completion of Evaluation
Upon completion of our evaluation, including evaluation of comments
received as a result of this notice, we will publish a notice in the
Federal Register announcing the result of our evaluation. Section
1852(e)(4)(C) of the Act provides a statutory timetable to ensure that
our review of deeming applications is conducted in a timely manner. The
Act provides us with 210 calendar days after the date of receipt of an
application to complete our survey activities and application review
process. At the end of the 210-day period, we must publish an approval
or denial of the application in the Federal Register.
III. Collection of Information Requirements
This document does not impose information collection requirements,
that is, reporting, recordkeeping or third-party disclosure
requirements. Consequently, there is no need for review by the Office
of Management and Budget under the authority of the Paperwork Reduction
Act of 1995 (44 U.S.C. 3501 et seq.).
IV. Response to Comments
Because of the large number of public comments we normally receive
on Federal Register documents, we are not able to acknowledge or
respond to them individually. We will consider all comments we receive
by the date and time specified in the DATES section of this preamble,
and, when we proceed with a subsequent document, we will respond to the
comments in the preamble to that document.
Dated: December 14, 2018.
Seema Verma,
Administrator, Centers for Medicare & Medicaid Services.
[FR Doc. 2018-27802 Filed 12-21-18; 8:45 am]
BILLING CODE 4120-01-P